This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: University of Kansas. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Fei Philip Gao: Innovator in Pharmaceutical Compounds
Introduction
Fei Philip Gao is a notable inventor based in Lawrence, KS (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on compounds that enhance the efficacy of therapeutic antibodies.
Latest Patents
Fei Philip Gao holds 1 patent related to Kifunensine derivatives. This patent discloses compounds according to Formula I or a pharmaceutically acceptable salt and/or solvate thereof. The compounds are designed to upregulate CD20 by inhibiting a-mannosidase enzymes, which potentiates the activity of anti-CD20 monoclonal antibodies. This technology is particularly important as it sensitizes cell lines that are resistant to these antibodies.
Career Highlights
Fei Philip Gao is affiliated with the University of Kansas, where he continues to advance research in pharmaceutical sciences. His work has implications for improving treatments for various diseases, particularly those involving immune responses.
Collaborations
Fei Philip Gao has collaborated with notable colleagues such as Patrick Andrew Ross and Suresh Eknath Kurhade. Their combined expertise contributes to the innovative research being conducted at the University of Kansas.
Conclusion
Fei Philip Gao's contributions to the field of pharmaceuticals through his patent on Kifunensine derivatives highlight his role as an innovator. His work not only advances scientific knowledge but also has the potential to improve therapeutic strategies for patients.